As most will say, depends on the specific analyst.
A lot of Stifel Analysts are ex-Leerink, so that says something about SVBL. Overall as a whole SVBL should be your top pick, especially if you're actually in Biotech ER (vs pharma, services, large caps etc).
Atque doloribus natus quas ipsum laborum sequi omnis. Nam vel repellendus praesentium expedita eum perferendis eaque.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
Sorry, you need to login or sign up in order to vote. As a new user, you get over 200 WSO Credits free,
so you can reward or punish any content you deem worthy right away. See you on the other side!
As most will say, depends on the specific analyst.
A lot of Stifel Analysts are ex-Leerink, so that says something about SVBL. Overall as a whole SVBL should be your top pick, especially if you're actually in Biotech ER (vs pharma, services, large caps etc).
.
Im not too familiar with Biotech but SVB is really big on health-related research
Leerink.
Looks like SVB was not the right answer here lol. Can anyone expand on why BTIG or BMO suck?
Depends on the specific analyst but SVB is probably the best platform out of them.
Atque doloribus natus quas ipsum laborum sequi omnis. Nam vel repellendus praesentium expedita eum perferendis eaque.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...